HaghighiKian Seyed Masoud, Shirinzadeh-Dastgiri Ahmad, Vakili-Ojarood Mohammad, Naseri Amirhosein, Barahman Maedeh, Saberi Ali, Rahmani Amirhossein, Shiri Amirmasoud, Masoudi Ali, Aghasipour Maryam, Shahbazi Amirhossein, Ghelmani Yaser, Aghili Kazem, Neamatzadeh Hossein
Department of General Surgery, School of Medicine, Hazrat-E Rasool General Hospital, Iran University of Medical Sciences, Tehran, Iran.
Department of Surgery, School of Medicine, Shohadaye Haft-E Tir Hospital, Iran University of Medical Sciences, Tehran, Iran.
Indian J Surg Oncol. 2025 Feb;16(1):257-278. doi: 10.1007/s13193-024-02079-6. Epub 2024 Sep 5.
The application of artificial intelligence (AI) in lung cancer, particularly in surgical approaches, has significantly transformed the healthcare landscape. AI has demonstrated remarkable advancements in early lung cancer detection, precise medical image analysis, and personalized treatment planning, all of which are crucial for surgical interventions. By analyzing extensive datasets, AI algorithms can identify patterns and anomalies in lung scans, facilitating timely diagnoses and enhancing surgical outcomes. Furthermore, AI can detect subtle indicators that may be overlooked by human practitioners, leading to quicker intervention and more effective treatment strategies. The technology can also predict patient responses to surgical treatments, enabling tailored care plans that improve recovery rates. In addition to surgical applications, AI streamlines administrative tasks such as record management and appointment scheduling, allowing healthcare providers to concentrate on delivering high-quality care. The integration of AI with genomics and precision medicine holds the potential to further refine surgical approaches in lung cancer treatment by developing targeted strategies that enhance effectiveness and minimize side effects. Despite challenges related to data privacy and regulatory concerns, the ongoing advancements in AI, coupled with collaboration between healthcare professionals and AI experts, suggest a promising future for lung cancer care. This article explores how AI addresses the challenges of lung cancer treatment, focusing on current advancements, obstacles, and the future potential of surgical applications.
人工智能(AI)在肺癌领域的应用,尤其是在手术方法方面,已经显著改变了医疗格局。人工智能在早期肺癌检测、精确医学图像分析和个性化治疗规划方面取得了显著进展,所有这些对于手术干预都至关重要。通过分析大量数据集,人工智能算法可以识别肺部扫描中的模式和异常,促进及时诊断并改善手术结果。此外,人工智能可以检测出人类从业者可能忽略的细微指标,从而实现更快的干预和更有效的治疗策略。该技术还可以预测患者对手术治疗的反应,制定出能够提高康复率的个性化护理计划。除了手术应用外,人工智能还简化了诸如记录管理和预约安排等行政任务,使医疗服务提供者能够专注于提供高质量的护理。人工智能与基因组学和精准医学的整合,有可能通过制定提高疗效并将副作用降至最低的靶向策略,进一步优化肺癌治疗的手术方法。尽管存在数据隐私和监管方面的挑战,但人工智能的不断进步,加上医疗专业人员与人工智能专家之间的合作,预示着肺癌护理的前景光明。本文探讨了人工智能如何应对肺癌治疗的挑战,重点关注当前的进展、障碍以及手术应用的未来潜力。